Adaptive Biotechnologies (ADPT) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? A quick glance at the ...

Adaptive Biotechnologies (ADPT) shares rallied 18% in the last trading session to close at $7.16. This move can be attributable to notable volume with a higher number of shares being traded than ...

Pairing Adaptive Biotechnologies’ clonoSEQ MRD results with NeoGenomics’ COMPASS and CHART assessment services empowers clinicians and patients with meaningful insights ...

Dive into 3 major technological pursuits at the Department of Defense in its fight to stay agile and effective in evolving environments.

Ark Invest’s Ark Innovation ETF ARKK fund sold 140,518 shares of Palantir. This move is significant, considering Ark Invest’s recent trend of offloading Palantir shares. The total value of ...

NEW YORK (AP) — U.S. stock indexes closed their best week in two months with a flourish on Friday. The S&P 500 climbed 1% to clinch its first winning week in the last three. The Dow Jones ...

Terry has 25 years experience in journalism and communications, reporting on a range of topics that include personal finance, telecommunications, Congress, government regulations, and criminal ...

The Fund seeks long-term growth of capital. The Fund invests at least 80% of its net assets in equity securities of US companies such as common stocks, depositary receipts, and REITs. Stocks are ...